BioCardia takes a new and comprehensive approach to heart failure
We are a clinical-stage regenerative medicine company committed to developing novel therapeutics to improve the lives of patients suffering from cardiovascular diseases with large unmet medical needs.
Discover us
Financials & Filings
Review our corporate financial reports and SEC filings
Press Releases
Read about our latest company milestones
Clinical Trials
If you or a loved one would like to find out if you qualify to participate in our CardiAMP Heart Failure Study
Complete Questionnaire
Complete Questionnaire
Product Pipeline
Learn about our product development programs and obtain an at-a-glance view of their current status
News
11 May

University of Minnesota
Investigational Therapy Exploring Treatment of Heart Failure Seeks to Stimulate Body’s Natural Healing Response
16 Apr

Saint Joseph Mercy
St. Joseph Mercy Ann Arbor to perform clinical trial using stem cells to treat congestive heart failure
31 Jan

03 Oct

BioWorld Med Tech
Biocardia presses on with Cardiamp pivotal trial to treat patients with heart failure
26 May

24 May

18 Apr

05 Mar

01 Mar

News Center Watch
Johns Hopkins, MSCRF, BioCardia treat first patient with CardiAMP in ischemic heart failure trial
press releases
Have questions?
call us now
call us now
: (800) 624-1179
Have questions?
Email us now
Email us now
: info@biocardia.com
biocardia takes a new and comprehensive
approach to heart failure
By introducing patient screening and highly-efficient delivery to stem cell therapy, the company seeks to increase the likelihood of treatment success, enabling more patients to return to the things they love.